Learning Hub Central

Leukemia

2025 MCM | Acute Myeloid Leukemia

2025 MCM | Acute Myeloid Leukemia

Leukemia

1 Chapter

Non-CME Credit Course

2025 MCM | Chronic Lymphocytic Leukemia

2025 MCM | Chronic Lymphocytic Leukemia

Leukemia

1 Chapter

Non-CME Credit Course

2023 UCT | New Developments in CLL

2023 UCT | New Developments in CLL

Leukemia

1 Chapter

Non-CME Credit Course

2018 AIO | Advances in Cellular Therapy

2018 AIO | Advances in Cellular Therapy

Leukemia

1 Chapter

Non-CME Credit Course

2021 NOSCM | CLL: Novel Therapies

2021 NOSCM | CLL: Novel Therapies

Leukemia

1 Chapter

Non-CME Credit Course

2022 MCM | Chronic Lymphocytic Leukemias

2022 MCM | Chronic Lymphocytic Leukemias

Leukemia

1 Chapter

Non-CME Credit Course

2022 NOSCM | Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL

2022 NOSCM | Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL

Leukemia

1 Chapter

Non-CME Credit Course

AML and MDS: Current Status and Future Directions

AML and MDS: Current Status and Future Directions

Leukemia

1 Chapter

Non-CME Credit Course

2022 CCC | Advance in Treatment of Acute Lymphocyctic Leukemia

2022 CCC | Advance in Treatment of Acute Lymphocyctic Leukemia

Leukemia

1 Chapter

Non-CME Credit Course

Acute Myeloid Leukemia

Acute Myeloid Leukemia

Leukemia

1 Chapter

Non-CME Credit Course

Update on Therapy Options for Untreated and Relapsed CLL

Update on Therapy Options for Untreated and Relapsed CLL

Leukemia

1 Chapter

Non-CME Credit Course

2024 PRIMO | AML: Where Are We Now and Where Are We Going?

2024 PRIMO | AML: Where Are We Now and Where Are We Going?

Leukemia

1 Chapter

Non-CME Credit Course

2024 MCM | Myelodysplasia: De Novo and Acquired- What To Do?

2024 MCM | Myelodysplasia: De Novo and Acquired- What To Do?

Leukemia

1 Chapter

Non-CME Credit Course

2024 NOSCM | CLL: Therapeutic Advances in 2024

2024 NOSCM | CLL: Therapeutic Advances in 2024

Leukemia

1 Chapter

Non-CME Credit Course

2024 NOSCM | Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR/ABL, FLT3, IDH1/2)

2024 NOSCM | Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR/ABL, FLT3, IDH1/2)

Leukemia

1 Chapter

Non-CME Credit Course

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

Leukemia

1 Chapter

Non-CME Credit Course

2022 AIO | Recent Advances in Acute Leukemias

2022 AIO | Recent Advances in Acute Leukemias

Leukemia

1 Chapter

Non-CME Credit Course

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Leukemia

1 Chapter

Non-CME Credit Course

MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo